Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
50 participants
INTERVENTIONAL
2008-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Membrane Blue Versus Infracyanine Green
NCT00555269
Brillant Blue Versus Indocyanine Green for Macular Hole Surgery
NCT00757471
Infracyanine Green vs Brilliant Blue G in Macular Hole Inverted Flap Surgery: A Swept Source OCT Analysis.
NCT03946267
Effect of the Membrane Blue Dual® Dye on the Retinal Sensitivity in Macular Hole Surgery
NCT02894424
Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery
NCT01820520
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Indocyanine green arm
Indocyanine green
Using indocyanine green as intraoperative dye
Brilliant blue
Brilliant blue arm
Using brilliant blue as intraoperative dye
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Indocyanine green
Using indocyanine green as intraoperative dye
Brilliant blue arm
Using brilliant blue as intraoperative dye
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* macular pucker or macular hole with subjective disturbances
* All phakic or pseudophakic patients
* far visual acuity better than 20/400
* able to read, understand, and willing to sign the informed consent form
Exclusion Criteria
* prior vitreoretinal surgery in the study eye
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Cologne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Cologne
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bernd Kirchhof, MD
Role: PRINCIPAL_INVESTIGATOR
University of Cologne, Center of Ophthalmology, 50924 Cologne, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center of Ophthalmology, University of Cologne
Cologne, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BlueIce001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.